Glucocorticoid receptor and breast cancer (Q37912048)

25 August 2017

1 reference

title

Glucocorticoid receptor and breast cancer (English)

1 reference

25 August 2017

1 reference

Myriam Vilasco

1 reference

25 August 2017

Laudine Communal

1 reference

25 August 2017

Najat Mourra

1 reference

25 August 2017

Aurélie Courtin

1 reference

25 August 2017

Patricia Forgez

1 reference

25 August 2017

Anne Gompel

1 reference

25 August 2017

language of work or name

English

0 references

publication date

5 August 2011

1 reference

full work available at URL

25 August 2017

http://link.springer.com/content/pdf/10.1007/s10549-011-1689-6.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

http://link.springer.com/article/10.1007/s10549-011-1689-6/fulltext.html

9 December 2024

file format

HyperText Markup Language

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

http://link.springer.com/content/pdf/10.1007/s10549-011-1689-6

9 December 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Breast Cancer Research and Treatment

9 December 2024

published in

1 reference

25 August 2017

volume

130

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

1-10

1 reference

25 August 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Effects of life event stress and social support on the odds of a >or= 2 cm breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Influence of stressors on breast cancer incidence in the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The role of the glucocorticoid receptor in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

X chromosomal abnormalities in basal-like human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The human glucocorticoid receptor: one gene, multiple proteins and diverse responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Cloning of the human glucocorticoid receptor cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

De-phosphorylation of GR at Ser203 in nuclei associates with GR nuclear translocation and GLUT5 gene expression in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glucocorticoid receptor phosphorylation differentially affects target gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

DNA binding of the glucocorticoid receptor is not essential for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glucocorticoid receptor expression in breast cancer associates with older patient age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Stressful Life Events and Risk of Breast Cancer in 10,808 Women: A Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Stress, depression, the immune system, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

NF-kappaB in cancer: a marked target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

AP-1 as a regulator of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The Fos family of transcription factors and their role in tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Sphingosine kinase signalling in immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Tumor necrosis factor or tumor promoting factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

High-dose, short-term, anti-inflammatory treatment with dexamethasone reduces growth and augments the effects of 5-fluorouracil on dimethyl-alpha-benzanthracene-induced mammary tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Glucocorticoid receptor-mediated chromatin remodeling in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Progesterone and Glucocorticoid Receptors Recruit Distinct Coactivator Complexes and Promote Distinct Patterns of Local Chromatin Modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid rece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Overlapping but distinct profiles of gene expression elicited by glucocorticoids and progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Progestins specifically suppress alpha-lactalbumin synthesis and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Progestogen therapies: differences in clinical effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: a quantitative review of published randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Hormone therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Transcriptional profiles of progestogen effects in the postmenopausal breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1689-6

Demonstration of glucocorticoid receptors in human mammary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis

9 December 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein

9 December 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Genetic dissection of glucocorticoid receptor function in mice

9 December 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Self-reported stress and risk of breast cancer

9 December 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Psychological stress and the risk of breast cancer: a case-control study

9 December 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

p53: The Attractive Tumor Suppressor in the Cancer Research Field

9 December 2024

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes

9 December 2024

106

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

Adrenal steroids as parameters of the bioavailability of MA and MPA

9 December 2024

108

1 reference

https://api.crossref.org/works/10.1007/S10549-011-1689-6

9 December 2024

Identifiers

1 reference

25 August 2017

1 reference